Cargando…
MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene
PURPOSE: Monocarboxylate transporter 4 (MCT4) is an important component of cancer cell glycolytic metabolism. It has been confirmed that MCT4 is highly expressed in hepatocellular carcinoma (HCC) cells and tissues and is significantly associated with poor prognosis of HCC patients. However, research...
Autores principales: | Niu, Zheyu, Yang, Faji, Li, Hongguang, Wang, Jianlu, Ni, Qingqiang, Ma, Chaoqun, Zhu, Huaqiang, Chang, Hong, Zhou, Xu, Lu, Jun, Gao, Hengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005128/ https://www.ncbi.nlm.nih.gov/pubmed/35425722 http://dx.doi.org/10.2147/JHC.S352948 |
Ejemplares similares
-
Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study
por: Han, Ziqiang, et al.
Publicado: (2022) -
Potential prognosis index for m(6)A-related mRNA in cholangiocarcinoma
por: Zhu, Huaqiang, et al.
Publicado: (2022) -
Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma
por: Gao, Hengjun, et al.
Publicado: (2020) -
Prognostic analysis of radical resection for iCCA(phl) and iCCA(pps): A retrospective cohort study
por: Yu, Zetao, et al.
Publicado: (2022) -
Intraductal papillary mucinous neoplasm of the biliary tract in the caudate lobe of the liver: a case report and literature review
por: Zhu, Xunhao, et al.
Publicado: (2023)